Who's who

3 Houston innovators to know this week

These three Houstonians have a lot up their sleeves for their companies. Courtesy photos

This week's three Houston entrepreneurs are all about improving access for startups — either to capital or to resources — and that's no small undertaking in a market like Houston. With its urban sprawl and large population, Houston's been considered to have a connectivity problem. Luckily, these three folks have solutions.

Grace Rodriguez, executive director and co-founder of Impact Hub Houston

Grace Rodriguez is the co-founder and executive director of Impact Hub Houston. Courtesy of Grace Rodriguez

Grace Rodriguez has been working to launch Impact Hub Houston for a while now, but her and her team's moment has come. For Rodriguez, the goal is to both advance Houston startups, as well as the innovation ecosystem as a whole.

"Our real vision is to help Houston become a role model for how the world solves the most pressing issues," she says. "We want to show the rest of the world that Houston has the talent, expertise, insight, and resources to solve issues around the world." Read more about Rodriguez and Impact Hub Houston here.

Nicolas Carnrite, co-founder of LetsLaunch

Nicolas Carnrite founded LetsLaunch to improve access to funding. Courtesy of LetsLaunch

Something didn't add up for Nicolas Carnrite. The opportunity to invest in companies was limited to such a small percentage of the population.

"There's something like 30 million people globally that have a $1 million net worth, which is the definition of being an accredited investor," Carnrite says. "Thirty million people out of 7.7 billion, so it's a little less than half a percentage."

This translated into an opportunity to create LetsLaunch, a securities investment online platform that democratizes investment. The Houston company has taken it a step further in its recent partnership with The Cannon. Read more about this partnership here.

Youngro Lee, co-founder and CEO of NextSeed

Youngro Lee NextSeed

Youngro Lee, co-founder and CEO of NextSeed, wants to create a connection between business and their communities. Courtesy of NextSeed

Thanks to a recent SEC accreditation, Youngro Lee is now able to announce that his Houston online fundraising platform, NextSeed, is a broker-dealer. The platform, which has helped the likes of Buffalo Bayou Brewery and The Waffle Bus raise thousands of capital dollars, is now able to offer its community more investment opportunities. Read more about what the deal means for the company here.

Trending News

Building Houston

 
 

Houston-based imaware, which has an at-home COVID-19 testing process, is working with Texas A&M University on researching how the virus affects the human body. Getty Images

An ongoing medical phenomenon is determining how COVID-19 affects people differently — especially in terms of severity. A new partnership between a Houston-based digital health platform and Texas A&M University is looking into differences in individual risk factors for the virus.

Imaware, which launched its at-home coronavirus testing kit in April, is using its data and information collected from the testing process for this new study on how the virus affects patients differently.

"As patient advocates, we want to aid in the search to understand more about why some patients are more vulnerable than others to the deadly complications of COVID-19," says Jani Tuomi, co-founder of imaware, in a press release. "Our current sample collection process is an efficient way to provide longitudinal prospectively driven data for research and to our knowledge, is the only such approach that is collecting, assessing, and biobanking specimens in real time."

Imaware uses a third-party lab to conduct the tests at patients' homes following the Center for Disease Control's guidelines and protocol. During the test, the medical professional takes additional swabs for the study. The test is then conducted by Austin-based Wheel, a telemedicine group.

Should the patient receive positive COVID-19 results, they are contacted by a representative of Wheel with further instructions. They are also called by a member of a team led by Dr. Rebecca Fischer, an infectious disease expert and epidemiologist and laboratory scientist at the Texas A&M University School of Public Health, to grant permission to be a part of the study.

Once a part of the study, the patient remains in contact with Fischer's team, which tracks the spread and conditions of the virus in the patient. One thing the researchers are looking for is the patients' responses to virus complications caused by an overabundance of cytokines, according to the press release. Cytokines are proteins in the body that fight viruses and infections, and, if not working properly, they can "trigger an over-exuberant inflammatory response" that can cause potentially deadly issues with lung and organ failure or worse, per the release.

"We believe strongly in supporting this research, as findings from the field can be implemented to improve clinical processes-- helping even more patients," says Wheel's executive medical director, Dr. Rafid Fadul.

Trending News